Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Dixon Investments Inc
FDA Inspection
•Dixon Investments Inc•January 25, 2010

Dixon Investments Inc – FDA Inspection, Jan 25, 2010

Record Details

This FDA Inspection record concerns Dixon Investments Inc, with an inspection on January 25, 2010, issued by the Center for Drug Evaluation and Research, covering drugs.

Company
Dixon Investments Inc
Inspection Date
January 25, 2010
Product Type
Drugs
Office
Center for Drug Evaluation and Research
View Company Profile

ID · fedfc68f-e4c9-4dc3-b464-bd6017ec6349

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number
646629
FDA center
Human Drugs
Project area
Drug Quality Assurance

FDA Citations

10
  1. 21 CFR 211.110(a)Control procedures to monitor and validate performance
  2. 21 CFR 211.25(a)GMP Training Frequency
  3. 21 CFR 211.160(b)Scientifically sound laboratory controls
  4. 21 CFR 211.198(a)Complaint Handling Procedure
  5. 21 CFR 211.100(a)Absence of Written Procedures
  6. 21 CFR 211.22(d)Procedures not in writing, fully followed
  7. 21 CFR 211.166(a)(2)Stability sample storage conditions described
  8. 21 CFR 211.166(a)Written program not followed
  9. 21 CFR 211.180(e)(2)Items to cover on annual reviews
  10. 21 CFR 211.182Written records kept in individual logs

Full citation text and observation details available on the Dashboard.

Other FDA inspections of Dixon Investments Inc

5
DateClassificationOfficeProject area
March 11, 2025OAIAtlanta District OfficeDrug Quality Assurance
March 22, 2019VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
December 16, 2015VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
December 6, 2013VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
December 13, 2011VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
Other documents for Dixon Investments Inc
  • FDA Inspection 1263416 - 2025-03-11
  • FDA Inspection 1083739 - 2019-03-22
  • FDA Inspection 956550 - 2015-12-16
  • FDA Inspection 858354 - 2013-12-06
  • FDA Inspection 758691 - 2011-12-13

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Dixon Investments Inc
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.